Skip to main content
ZTS logo

ZTS · Zoetis Inc. · Earnings Call Transcripts & Audio

Track ZTS — free
Market Cap
$31.33B
Shares
413.22M

Zoetis Inc. Earnings Call Transcripts

Quarterly earnings calls for Zoetis Inc. (ZTS), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.

Earnings call
FY26 · Q2
2026-08-06
Zoetis Inc. (ZTS) Q2 2026 Earnings Call Transcript
Revenue
$2.47B
▼ 0.2% YoY
Diluted EPS
$1.65
▲ 1.2% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2026-06-02
Zoetis Inc. (ZTS) June 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-05-28
Zoetis Inc. (ZTS) May 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q1
2026-05-07
Zoetis Inc. (ZTS) Q1 2026 Earnings Call Transcript
Cautious tone Competitive intensity Companion animal pressure OA Pain / Librela
Revenue
$2.26B
▲ 2.9% YoY
Diluted EPS
$1.42
▲ 6% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2026-03-10
Zoetis Inc. (ZTS) March 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY25 · Q4
2026-02-12
Zoetis Inc. (ZTS) Q4 2025 Earnings Call Transcript
Positive tone Livestock and international growth Simparica / Trio franchise 2026 financial guidance
Revenue
$2.40B*
▲ 3.4% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-12-02
Zoetis Inc. (ZTS) Q3 2025 Earnings Call Transcript
Positive tone OA pain franchise (Librela/Solensia/Lenivia/Portela) Innovation pipeline and approvals Parasiticides franchise (Simparica/Trio)
Revenue
$2.40B
▲ 0.5% YoY
Diluted EPS
$1.63
▲ 8.7% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-08-05
Zoetis Inc. (ZTS) Q2 2025 Earnings Call Transcript
Confident tone International and geographic growth Companion Animal franchise momentum Librela / OA Pain adoption challenges
Revenue
$2.47B
▲ 4.8% YoY
Diluted EPS
$1.63
▲ 19% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-06
Zoetis Inc. (ZTS) Q1 2025 Earnings Call Transcript
Confident tone Companion animal growth (Simparica, dermatology, OA pain) Librela / OA pain adoption ramp Tariffs and pharmaceutical policy (Section 232)
Revenue
$2.20B
▲ 0.4% YoY
Diluted EPS
$1.34
▲ 2.3% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-02-13
Zoetis Inc. (ZTS) Q4 2024 Earnings Call Transcript
Confident tone Companion animal growth and key franchises Osteoarthritis pain franchise (Librela/Solensia) 2025 financial guidance and outlook
Revenue
$2.32B*
▲ 4.7% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-11-04
Zoetis Inc. (ZTS) Q3 2024 Earnings Call Transcript
Confident tone Librela/Solensia (OA pain franchise) Dermatology franchise (Apoquel/Cytopoint) Simparica Trio (parasiticides)
Revenue
$2.39B
▲ 11% YoY
Diluted EPS
$1.50
▲ 16.3% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-08-06
Zoetis Inc. (ZTS) Q2 2024 Earnings Call Transcript
Confident tone Dermatology franchise (Apoquel/Cytopoint) Companion animal innovation (Librela/Solensia) Livestock portfolio
Revenue
$2.36B
▲ 8.3% YoY
Diluted EPS
$1.37
▼ 5.5% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-05-02
Zoetis Inc. (ZTS) Q1 2024 Earnings Call Transcript
Confident tone Companion animal / OA pain franchise (Librela, Solensia) Librela safety / FDA and vet engagement Parasiticides (Simparica, Simparica Trio)
Revenue
$2.19B
▲ 9.5% YoY
Diluted EPS
$1.31
▲ 10.1% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-02-13
Zoetis Inc. (ZTS) Q4 2023 Earnings Call Transcript
Confident tone Librela / Solensia (OA pain monoclonal antibodies) 2024 financial guidance and outlook Companion animal portfolio
Revenue
$2.21B*
▲ 8.5% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-11-02
Zoetis Inc. (ZTS) Q3 2023 Earnings Call Transcript
Revenue
$2.15B
▲ 7.4% YoY
Diluted EPS
$1.29
▲ 14.2% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-08-08
Zoetis Inc. (ZTS) Q2 2023 Earnings Call Transcript
Revenue
$2.18B
▲ 6.2% YoY
Diluted EPS
$1.45
▲ 29.5% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-05-04
Zoetis Inc. (ZTS) Q1 2023 Earnings Call Transcript
Revenue
$2.00B
▲ 0.7% YoY
Diluted EPS
$1.19
▼ 5.6% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-02-14
Zoetis Inc. (ZTS) Q4 2022 Earnings Call Transcript
Revenue
$2.04B*
▲ 3.7% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-11-03
Zoetis Inc. (ZTS) Q3 2022 Earnings Call Transcript
Revenue
$2.00B
▲ 0.6% YoY
Diluted EPS
$1.13
▼ 2.6% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-08-04
Zoetis Inc. (ZTS) Q2 2022 Earnings Call Transcript
Revenue
$2.05B
▲ 5.3% YoY
Diluted EPS
$1.12
▲ 4.7% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-05-05
Zoetis Inc. (ZTS) Q1 2022 Earnings Call Transcript
Revenue
$1.99B
▲ 6.1% YoY
Diluted EPS
$1.26
▲ 7.7% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-02-15
Zoetis Inc. (ZTS) Q4 2021 Earnings Call Transcript
Revenue
$1.97B*
▲ 8.9% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-11-04
Zoetis Inc. (ZTS) Q3 2021 Earnings Call Transcript
Revenue
$1.99B
▲ 11.4% YoY
Diluted EPS
$1.16
▲ 16% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-08-05
Zoetis Inc. (ZTS) Q2 2021 Earnings Call Transcript
Revenue
$1.95B
▲ 25.8% YoY
Diluted EPS
$1.07
▲ 35.4% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-05-06
Zoetis Inc. (ZTS) Q1 2021 Earnings Call Transcript
Revenue
$1.87B
▲ 22% YoY
Diluted EPS
$1.17
▲ 33% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2021-02-16
Zoetis Inc. (ZTS) Q4 2020 Earnings Call Transcript
Revenue
$1.81B*
▲ 7.9% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-11-05
Zoetis Inc. (ZTS) Q3 2020 Earnings Call Transcript
Revenue
$1.79B
▲ 12.8% YoY
Diluted EPS
$1.00
▲ 11.1% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-08-06
Zoetis Inc. (ZTS) Q2 2020 Earnings Call Transcript
Revenue
$1.55B
▲ 0.1% YoY
Diluted EPS
$0.79
▲ 2.6% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-05-06
Zoetis Inc. (ZTS) Q1 2020 Earnings Call Transcript
Revenue
$1.53B
▲ 5.4% YoY
Diluted EPS
$0.88
▲ 35.4% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY19 · Q4
2020-02-13
Zoetis Inc. (ZTS) Q4 2019 Earnings Call
Revenue
$1.67B
▲ 7% YoY
Diluted EPS
$0.80
▲ 12.7% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Showing 1–30 of 30 earnings calls
Key facts CIK 1555280 CUSIP 98978V103 13F (30d) 578 filings 563 filers Visit website Investor relations